We use cookies for a better user experience. Read our Privacy Policy

I Agree

Veterinary Molecular Diagnostics Market Trends, 2020-2030

Veterinary Molecular Diagnostics Market (Product Type: Instruments & Software, Kits & Reagents, and Services; Technology: Conventional PCR, Singleplex PCR, Multiplex PCR, Real-time PCR, and Others; Disease Type: Vector-borne Diseases, Respiratory Pathogens, Diarrhea Pathogens, and Others; Animal Type: Companion Animal and Livestock Animal; and End User: Hospitals/Clinics and Reference Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

New and Improved Diagnostic Techniques to Replace Conventional Diagnostic Methods

Research and development activities are likely to play a key role in driving the global veterinary molecular diagnostics market in the upcoming decade. Some of the recent novel and groundbreaking discoveries in diverse diagnostics and therapeutic tools pertaining to animal health are expected to open up new avenues for the players involved in the current veterinary molecular diagnostics market. Considerable progress made in the detection, management, and treatment of infectious and non-infectious diseases among animals is expected to fuel the demand for veterinary molecular diagnostics during the forecast period.

Innovations in the field of veterinary molecular diagnostics are primarily driven by advancements in technology, research, and increasing investments from private as well as non-private business entities. Progress in veterinary molecular diagnostics has also provided a considerable boost to the economies and food security of several developing nations, including India and China– a factor that is expected to boost the global veterinary molecular diagnostics market during the assessment period. The past and newly developed veterinary molecular diagnostic techniques play an imperative role in the detection and identification of new and emerging pathogens in livestock due to which, the adoption rates continue to move in the upward trajectory.

At the back of these factors, the global veterinary molecular diagnostics market is on course to attain a market value of US$ 1.1 Bn by the end of 2030.

Request a sample to get extensive insights into the Veterinary Molecular Diagnostics Market

Entry of New Vaccines and Improvements in Molecular Diagnostic Techniques to Aid Market Growth

The advent of new vaccines and recent progress made by veterinary molecular diagnostic techniques by opting for a genomic approach are anticipated to improve the overall state of veterinary molecular diagnostics worldwide and management of a range of infectious veterinary diseases. Noteworthy progress made by DNA sequencing platforms and major developments in the data analysis space are also some of the key factors that are expected to provide a solid boost to the overall development of the global veterinary molecular diagnostics market during the assessment period. A number of private as well as government laboratories involved in the current market landscape are increasingly focusing on improving the accuracy of their veterinary molecular diagnostics to gain a considerable advantage.

The increasing adoption of DNA sequencing platforms and the high-throughput data generated by leveraging these platforms are increasingly being analyzed by using computational genomics and bioinformatics– a trend that is projected to gain momentum over the course of the forecast period. Improvements in the data analysis space is expected to present a number of opportunities to the players involved in the current veterinary molecular diagnostics market to develop improved therapeutic and veterinary molecular diagnostics tools. This factor is expected to shape the growth of the global veterinary molecular diagnostics market.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Advancements in Diagnostic Technologies and Increasing Adoption of New Tools to Drive Market

For several decades, conventional laboratory diagnostics for veterinary pathogens have primarily relied on various techniques, including neutralization, enzyme-linked Immunosorbent Assay (ELISA), compliment fixation, and agar gel immunodiffusion. However, due to advancements in technology, veterinarians around the world are increasingly using new veterinary molecular diagnostic techniques, including Western blot and polymerase chain reaction (PCR), which is estimated to increase the demand for veterinary molecular diagnostics in the upcoming years. Although the adoption of conventional techniques remains steady, the incorporation of new molecular techniques is on the rise. Improved immunoassays, increased use of biosensors, adoption of nucleic acid diagnostics, and adoption of preteomic technologies are expected to pave the way for a bright future for the veterinary molecular diagnostics market.

Market Growth Likely to Remain Slower than Usual amid COVID-19 Pandemic

The onset of the novel COVID-19 pandemic is expected to have a strong impact on the overall growth of the global veterinary molecular diagnostics market in 2020. As the majority of the healthcare fraternity and research activities is increasingly focusing on the discovery of a new vaccine for the novel COVID-19 disease, the growth of the veterinary molecular diagnostics market is expected to remain slower than initial projections. The ongoing pandemic is likely to cut-short investments for the development of new veterinary molecular diagnostic techniques, particularly in 2020, as the primary focus continues to remain on pathological tests related to human beings.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Veterinary Molecular Diagnostics Market

Analysts’ Viewpoint

The global veterinary molecular diagnostics market is expected to expand at an impressive CAGR of ~8% during the forecast period. Increase in the number of research and development activities, entry of new veterinary molecular diagnostic methods, advancements in technology, rise in prevalence of vector-borne diseases, and growth in pet ownership worldwide are anticipated to drive the veterinary molecular diagnostics market during the forecast period. Players involved in the current market should focus on research and development, and explore the potential of collaborating with other players in the market to strengthen their market position.

Veterinary Molecular Diagnostics Market: Overview

  • Molecular diagnostics are laboratory methods to examine the RNA, DNA, or other proteins in animals and identify diseases or predisposition stage
  • Veterinary molecular diagnostics are essential for diagnosis of vector-borne diseases, respiratory pathogens, and diarrhea pathogens in companion as well as livestock animals
  • The global veterinary molecular diagnostics market has experienced significant growth in the last decade due to increase in pet ownership and rise in obesity among pets
  • Different technologies used for veterinary molecular diagnosis include conventional PCR, singleplex PCR, multiplex PCR, and real-time PCR

Veterinary Molecular Diagnostics: Market Drivers

  • Increase in companion animal ownership is a trend witnessed in the animal healthcare segment. Spending capacity on companion animals is also on the rise. According to the National Pet Owners Survey conducted by the American Pet Products Association (APPA) in 2018, around 68% of households own a companion animal or pet in the U.S.
  • Rise in obesity among pets and increase in awareness about veterinary diagnostics are projected to drive the global veterinary molecular diagnostics market during the forecast period. According to a report by the Association for Pet Obesity Prevention (APOP), obesity affected around 55.8% of dogs and 59.5% of cats in the U.S. in 2018.

Market Segmentation: Veterinary Molecular Diagnostics Market

  • In terms of product type, the global veterinary molecular diagnostics market has been classified into instruments & software, kits & reagents, and services. The kits & reagents segment is anticipated to dominate the global veterinary molecular diagnostics market during the forecast period.
  • Based on technology, the global veterinary molecular diagnostics market has been categorized into conventional PCR, singleplex PCR, multiplex PCR, real-time PCR, and others
  • In terms of disease type, the global veterinary molecular diagnostics market has been divided into vector-borne diseases, respiratory pathogens, diarrhea pathogens, and others
  • Based on animal type, the global veterinary molecular diagnostics market has been bifurcated into companion animals and livestock animals. The companion animals segment has been split into canine, feline, and others.
  • In terms of end user, the global veterinary molecular diagnostics market has been segregated into hospitals/clinics and reference laboratories. The reference laboratories segment dominated the global veterinary molecular diagnostics market in terms of revenue in 2019.
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Veterinary Molecular Diagnostics Market

  • In terms of region, the global veterinary molecular diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and expected market revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2020 to 2030
  • The study also offers a list of recommendations, highlights, and useful insights of the global veterinary molecular diagnostics market, which would help new companies willing to enter the market, and existing companies to increase market shares and in the decision-making process

Veterinary Molecular Diagnostics Market: Major Players

  • The veterinary molecular diagnostics market report concludes with the company profiles section, which includes key information about major players in the global veterinary molecular diagnostics market
  • Leading players analyzed in the veterinary molecular diagnostics market report include
    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Zoetis, Inc.
    • Neogen Corporation
    • bioMérieux SA
    • QIAGEN N.V.
    • Biomedica Medizinprodukte GmbH & Co KG
    • Bioneer
    • VCA, Inc. (subsidiary of Mars, Incorporated)
    • ID.VET
  • Each of these players has been profiled in the veterinary molecular diagnostics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Veterinary Molecular Diagnostics Market – Segmentation

TMR’s study on the global veterinary molecular diagnostics market includes information divided into the following segments: product type, technology, disease type, animal type, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global veterinary molecular diagnostics market are discussed in detail.

Product Type

  • Instruments & Software
  • Kits & Reagents
  • Services

Technology

  • Conventional PCR
  • Singleplex PCR
  • Multiplex PCR
  • Real-time PCR
  • Others

Disease Type

  • Vector-borne Diseases
  • Respiratory Pathogens
  • Diarrhea Pathogens
  • Others

Animal Type

  • Companion Animal
  • Livestock Animal

End User

  • Hospitals/Clinics
  • Reference Laboratories

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of veterinary molecular diagnostics market?

The global veterinary molecular diagnostics market was worth US$ 479.3 Mn and is projected to reach a value of US$ 1.1 Bn by the end of 2030

What is the anticipated CAGR of the veterinary molecular diagnostics market in the forecast period?

Veterinary molecular diagnostics market is anticipated to grow at a CAGR of 8% during the forecast period

Which region is expected to project the highest market share in the global veterinary molecular diagnostics market?

North America accounted for a major share of the global veterinary molecular diagnostics market

What are the key driving factors for the growth of the veterinary molecular diagnostics market?

Veterinary Molecular Diagnostics Market is driven by rise in obesity among pets and increase in awareness about veterinary diagnostics

Who are the key players in the global veterinary molecular diagnostics market?

Key players in the global veterinary molecular diagnostics market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., Zoetis, Inc., Neogen Corporation, bioMérieux SA, QIAGEN N.V., Biomedica Medizinprodukte GmbH & Co KG, Bioneer, VCA, Inc. (subsidiary of Mars, Incorporated), and ID.VET.

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Key Industry Developments

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

    4.4. Global Veterinary Molecular Diagnostics Market Forecast

    4.5. Global Veterinary Molecular Diagnostics Market Outlook

5. Market Outlook

    5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

    5.2. Pet Ownership Statistics

    5.3. List of Pathogens for responsible for Canine, Feline, and Equine Diseases

    5.4. Covid-19 Impact Analysis

    5.5. Pros and Cons of Each Type of PCR Test

    5.6. Technological Advancement

    5.7. Most commonly Used Instruments for Veterinary Diagnostics

    5.8. Veterinary Medical Device Regulation

6. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

    6.1. Introduction

    6.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    6.3. Global Veterinary Molecular Diagnostics Market Forecast, by Product Type

        6.3.1. Instruments & Software

        6.3.2. Kits & Reagents

        6.3.3. Services

    6.4. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

7. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

    7.1. Introduction

    7.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    7.3. Global Veterinary Molecular Diagnostics Market Forecast, by Technology

        7.3.1. Conventional PCR

        7.3.2. Singleplex PCR

        7.3.3. Multiplex PCR

        7.3.4. Real-time PCR

        7.3.5. Others

    7.4. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

8. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

    8.1. Introduction

    8.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    8.3. Global Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        8.3.1. Vector-borne Diseases

        8.3.2. Respiratory Pathogens

        8.3.3. Diarrhea Pathogens

        8.3.4. Others

    8.4. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

    9.1. Introduction

    9.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    9.3. Global Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        9.3.1. Companion Animals

            9.3.1.1. Canine

            9.3.1.2. Feline

            9.3.1.3. Others

        9.3.2. Livestock Animals

    9.4. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

10. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

    10.1. Introduction

    10.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    10.3. Global Veterinary Molecular Diagnostics Market Forecast, by End-user

        10.3.1. Hospitals/Clinics

        10.3.2. Reference Laboratories

    10.4. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

11. Global Veterinary Molecular Diagnostics Market Analysis, by Region

    11.1. Global Veterinary Molecular Diagnostics Market Scenario, by Region/Country

    11.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Region

    11.3. Global Veterinary Molecular Diagnostics Market Forecast, by Region

        11.3.1. North America

        11.3.2. Europe

        11.3.3. Asia Pacific

        11.3.4. Latin America

        11.3.5. Middle East & Africa

12. North America Veterinary Molecular Diagnostics Market Analysis

    12.1. North America Veterinary Molecular Diagnostics Market Overview

    12.2. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country

    12.3. North America Veterinary Molecular Diagnostics Market Forecast, by Country

        12.3.1. U.S.

        12.3.2. Canada

    12.4. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    12.5. North America Veterinary Molecular Diagnostics Market Forecast, by Product Type

        12.5.1. Instruments & Software

        12.5.2. Kits & Reagents

        12.5.3. Services

    12.6. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    12.7. North America Veterinary Molecular Diagnostics Market Forecast, by Technology

        12.7.1. Conventional PCR

        12.7.2. Singleplex PCR

        12.7.3. Multiplex PCR

        12.7.4. Real-time PCR

        12.7.5. Others

    12.8. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    12.9. North America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        12.9.1. Vector-borne Diseases

        12.9.2. Respiratory Pathogens

        12.9.3. Diarrhea Pathogens

        12.9.4. Others

    12.10. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    12.11. North America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        12.11.1. Companion Animals

            12.11.1.1. Canine

            12.11.1.2. Feline

            12.11.1.3. Others

        12.11.2. Livestock Animals

    12.12. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    12.13. North America Veterinary Molecular Diagnostics Market Forecast, by End-user

        12.13.1. Hospitals/Clinics

        12.13.2. Reference Laboratories

13. Europe Veterinary Molecular Diagnostics Market Analysis

    13.1. Europe Veterinary Molecular Diagnostics Market Overview

    13.2. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Europe Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        13.3.1. Germany

        13.3.2. U.K.

        13.3.3. France

        13.3.4. Italy

        13.3.5. Spain

        13.3.6. Rest of Europe

    13.4. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    13.5. Europe Veterinary Molecular Diagnostics Market Forecast, by Product Type

        13.5.1. Instruments & Software

        13.5.2. Kits & Reagents

        13.5.3. Services

    13.6. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    13.7. Europe Veterinary Molecular Diagnostics Market Forecast, by Technology

        13.7.1. Conventional PCR

        13.7.2. Singleplex PCR

        13.7.3. Multiplex PCR

        13.7.4. Real-time PCR

        13.7.5. Others

    13.8. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    13.9. Europe Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        13.9.1. Vector-borne Diseases

        13.9.2. Respiratory Pathogens

        13.9.3. Diarrhea Pathogens

        13.9.4. Others

    13.10. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    13.11. Europe Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        13.11.1. Companion Animals

            13.11.1.1. Canine

            13.11.1.2. Feline

            13.11.1.3. Others

        13.11.2. Livestock Animals

    13.12. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    13.13. Europe Veterinary Molecular Diagnostics Market Forecast, by End-user

        13.13.1. Hospitals/Clinics

        13.13.2. Reference Laboratories

14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis

    14.1. Asia Pacific Veterinary Molecular Diagnostics Market Overview

    14.2. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        14.3.1. China

        14.3.2. Japan

        14.3.3. India

        14.3.4. Australia & New Zealand

        14.3.5. Rest of Asia Pacific

    14.4. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    14.5. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Product Type

        14.5.1. Instruments & Software

        14.5.2. Kits & Reagents

        14.5.3. Services

    14.6. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    14.7. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Technology

        14.7.1. Conventional PCR

        14.7.2. Singleplex PCR

        14.7.3. Multiplex PCR

        14.7.4. Real-time PCR

        14.7.5. Others

    14.8. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    14.9. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        14.9.1. Vector-borne Diseases

        14.9.2. Respiratory Pathogens

        14.9.3. Diarrhea Pathogens

        14.9.4. Others

    14.10. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    14.11. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        14.11.1. Companion Animals

            14.11.1.1. Canine

            14.11.1.2. Feline

            14.11.1.3. Others

        14.11.2. Livestock Animals

    14.12. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    14.13. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by End-user

        14.13.1. Hospitals/Clinics

        14.13.2. Reference Laboratories

15. Latin America Veterinary Molecular Diagnostics Market Analysis

    15.1. Latin America Veterinary Molecular Diagnostics Market Overview

    15.2. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    15.3. Latin America Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        15.3.1. Brazil

        15.3.2. Mexico

        15.3.3. Rest of Latin America

    15.4. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    15.5. Latin America Veterinary Molecular Diagnostics Market Forecast, by Product Type

        15.5.1. Instruments & Software

        15.5.2. Kits & Reagents

        15.5.3. Services

    15.6. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    15.7. Latin America Veterinary Molecular Diagnostics Market Forecast, by Technology

        15.7.1. Conventional PCR

        15.7.2. Singleplex PCR

        15.7.3. Multiplex PCR

        15.7.4. Real-time PCR

        15.7.5. Others

    15.8. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    15.9. Latin America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        15.9.1. Vector-borne Diseases

        15.9.2. Respiratory Pathogens

        15.9.3. Diarrhea Pathogens

        15.9.4. Others

    15.10. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    15.11. Latin America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        15.11.1. Companion Animals

            15.11.1.1. Canine

            15.11.1.2. Feline

            15.11.1.3. Others

        15.11.2. Livestock Animals

    15.12. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    15.13. Latin America Veterinary Molecular Diagnostics Market Forecast, by End-user

        15.13.1. Hospitals/Clinics

        15.13.2. Reference Laboratories

16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis

    16.1. Middle East & Africa Veterinary Molecular Diagnostics Market Overview

    16.2. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    16.3. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        16.3.1. GCC Countries

        16.3.2. South Africa

        16.3.3. Rest of Middle East & Africa

    16.4. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    16.5. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Product Type

        16.5.1. Instruments & Software

        16.5.2. Kits & Reagents

        16.5.3. Services

    16.6. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    16.7. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Technology

        16.7.1. Conventional PCR

        16.7.2. Singleplex PCR

        16.7.3. Multiplex PCR

        16.7.4. Real-time PCR

        16.7.5. Others

    16.8. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    16.9. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        16.9.1. Vector-borne Diseases

        16.9.2. Respiratory Pathogens

        16.9.3. Diarrhea Pathogens

        16.9.4. Others

    16.10. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    16.11. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        16.11.1. Companion Animals

            16.11.1.1. Canine

            16.11.1.2. Feline

            16.11.1.3. Others

        16.11.2. Livestock Animals

    16.12. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    16.13. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by End-user

        16.13.1. Hospitals/Clinics

        16.13.2. Reference Laboratories

17. Competition Landscape

    17.1. Competition Matrix

    17.2. Global Veterinary Molecular Diagnostics Market Share Analysis, by Company

    17.3. Company Profiles

        17.3.1. IDEXX Laboratories, Inc.

            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.1.2. Financial Overview

            17.3.1.3. Product Portfolio

            17.3.1.4. SWOT Analysis

            17.3.1.5. Strategic Overview

        17.3.2. Thermo Fisher Scientific, Inc.

            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.2.2. Financial Overview

            17.3.2.3. Product Portfolio

            17.3.2.4. SWOT Analysis

            17.3.2.5. Strategic Overview

        17.3.3. Zoetis, Inc.

            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.3.2. Financial Overview

            17.3.3.3. Product Portfolio

            17.3.3.4. SWOT Analysis

            17.3.3.5. Strategic Overview

        17.3.4. Neogen Corporation

            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.4.2. Product Portfolio

            17.3.4.3. SWOT Analysis

            17.3.4.4. Strategic Overview

        17.3.5. bioMérieux SA

            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.5.2. Financial Overview

            17.3.5.3. Product Portfolio

            17.3.5.4. SWOT Analysis

            17.3.5.5. Strategic Overview

        17.3.6. QIAGEN N.V.

            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.6.2. Financial Overview

            17.3.6.3. Product Portfolio

            17.3.6.4. SWOT Analysis

            17.3.6.5. Strategic Overview

        17.3.7. Biomedica Medizinprodukte GmbH & Co KG

            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.7.2. Product Portfolio

            17.3.7.3. SWOT Analysis

            17.3.7.4. Strategic Overview

        17.3.8. Bioneer

            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.8.2. Product Portfolio

            17.3.8.3. SWOT Analysis

            17.3.8.4. Strategic Overview

        17.3.9. VCA, Inc. (subsidiary of Mars, Incorporated)

            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.9.2. Product Portfolio

            17.3.9.3. SWOT Analysis

            17.3.9.4. Strategic Overview

        17.3.10. ID.VET

            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.10.2. Product Portfolio

            17.3.10.3. SWOT Analysis

            17.3.10.4. Strategic Overview

List of Tables

Table 01: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 02: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 03: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 04: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 05: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 06: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 07: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 08: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 09: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 10: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 11: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 12: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 13: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 14: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 15: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 16: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 17: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 18: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 19: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 20: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 21: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 25: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 26: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 27: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 28: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 29: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 30: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 31: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 32: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 33: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 34: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 35: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 37: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 38: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 39: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 40: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 41: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 42: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Veterinary Molecular Diagnostics Market Value Share, by Product Type, 2019

Figure 03: Global Veterinary Molecular Diagnostics Market Value Share, by Distribution Channel, 2019

Figure 04: Global Veterinary Molecular Diagnostics Market Value Share, by Disease Type, 2019

Figure 06: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2019

Figure 07: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2019

Figure 08: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 09: Global l Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 10: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Instruments & Software, 2018–2030

Figure 11: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Kits & Reagents, 2018–2030

Figure 12: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Services, 2018–2030

Figure 13: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030

Figure 14: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030

Figure 15: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Conventional PCR, 2018–2030

Figure 16: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Singleplex PCR, 2018–2030

Figure 17: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Multiplex PCR, 2018–2030

Figure 18: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Real-time PCR, 2018–2030

Figure 19: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Others, 2018–2030

Figure 20: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030

Figure 21: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030

Figure 22: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Vector-borne Diseases, 2018–2030

Figure 23: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Respiratory Pathogens, 2018–2030

Figure 24: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Diarrhea Pathogens, 2018–2030

Figure 25: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Others, 2018–2030

Figure 26: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 27: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 28: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Companion Animals, 2018–2030

Figure 29: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Livestock Animals, 2018–2030

Figure 30: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 31: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 32: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Hospitals/Clinics, 2018–2030

Figure 33: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Reference Laboratories, 2018–2030

Figure 34: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Region, 2019 and 2030

Figure 35: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Region

Figure 36: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 37: North America Veterinary Molecular Diagnostics Market Value Share (%), by Country, 2019 and 2030

Figure 38: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country, 2020–2030

Figure 39: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 40: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 41: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030

Figure 42: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030

Figure 43: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030

Figure 44: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030

Figure 45: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 46: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 47: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 48: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 49: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 50: Europe Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 51: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 52: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 53: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 54: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030

Figure 55: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030

Figure 56: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030

Figure 57: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030

Figure 58: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 59: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 60: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 61: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 62: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 63: Asia Pacific Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 64: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 65: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 66: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 67: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030

Figure 68: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030

Figure 69: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030

Figure 70: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030

Figure 71: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 72: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 73: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 74: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 75: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 76: Latin America Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 77: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 78: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 79: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 80: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030

Figure 81: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030

Figure 82: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030

Figure 83: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030

Figure 84: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 85: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 86: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 87: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 88: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 89: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 90: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 91: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 92: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 93: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030

Figure 94: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030

Figure 95: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030

Figure 96: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030

Figure 97: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 98: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 99: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 100: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved